Peter R Brown
Examiner (ID: 14886)
Most Active Art Unit | 3636 |
Art Unit(s) | 3507, 3636, 3508, 3624 |
Total Applications | 3230 |
Issued Applications | 2605 |
Pending Applications | 120 |
Abandoned Applications | 505 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 1053315
[patent_doc_number] => 06858644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-22
[patent_title] => 'Paclitaxel solvates'
[patent_app_type] => utility
[patent_app_number] => 10/304615
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9655
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/858/06858644.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304615
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304615 | Paclitaxel solvates | Nov 25, 2002 | Issued |
Array
(
[id] => 6856838
[patent_doc_number] => 20030130339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'ALPHA, BETA-UNSATURATED SULFONES FOR TREATING PROLIFERATIVE DISORDERS'
[patent_app_type] => new
[patent_app_number] => 10/301332
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9725
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130339.pdf
[firstpage_image] =>[orig_patent_app_number] => 10301332
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/301332 | Alpha, beta-unsaturated sulfones for treating proliferative disorders | Nov 20, 2002 | Issued |
Array
(
[id] => 1216944
[patent_doc_number] => 06706756
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-16
[patent_title] => 'Vasodilating compound and method of use'
[patent_app_type] => B1
[patent_app_number] => 10/065770
[patent_app_country] => US
[patent_app_date] => 2002-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 2469
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/706/06706756.pdf
[firstpage_image] =>[orig_patent_app_number] => 10065770
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/065770 | Vasodilating compound and method of use | Nov 17, 2002 | Issued |
Array
(
[id] => 6797620
[patent_doc_number] => 20030176494
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections'
[patent_app_type] => new
[patent_app_number] => 10/295340
[patent_app_country] => US
[patent_app_date] => 2002-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 31727
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20030176494.pdf
[firstpage_image] =>[orig_patent_app_number] => 10295340
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/295340 | Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections | Nov 14, 2002 | Abandoned |
Array
(
[id] => 535798
[patent_doc_number] => 07176217
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-02-13
[patent_title] => 'Azabicyclo compound matrix metalloprotease inhibitor and skin preparation'
[patent_app_type] => utility
[patent_app_number] => 10/495370
[patent_app_country] => US
[patent_app_date] => 2002-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16166
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/176/07176217.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495370
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495370 | Azabicyclo compound matrix metalloprotease inhibitor and skin preparation | Nov 12, 2002 | Issued |
Array
(
[id] => 1197119
[patent_doc_number] => 06727277
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-04-27
[patent_title] => 'Compounds affecting cholesterol absorption'
[patent_app_type] => B1
[patent_app_number] => 10/292720
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16721
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/727/06727277.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292720 | Compounds affecting cholesterol absorption | Nov 11, 2002 | Issued |
Array
(
[id] => 1339138
[patent_doc_number] => 06593481
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-15
[patent_title] => 'Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran'
[patent_app_type] => B1
[patent_app_number] => 10/292557
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3715
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/593/06593481.pdf
[firstpage_image] =>[orig_patent_app_number] => 10292557
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/292557 | Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran | Nov 11, 2002 | Issued |
Array
(
[id] => 501777
[patent_doc_number] => 07205407
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-17
[patent_title] => '3-Substituted oxindole β3 agonists'
[patent_app_type] => utility
[patent_app_number] => 10/495085
[patent_app_country] => US
[patent_app_date] => 2002-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11729
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/205/07205407.pdf
[firstpage_image] =>[orig_patent_app_number] => 10495085
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/495085 | 3-Substituted oxindole β3 agonists | Nov 11, 2002 | Issued |
Array
(
[id] => 490094
[patent_doc_number] => 07214707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-08
[patent_title] => 'Dimeric compounds and their use as anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 10/494242
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8970
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/214/07214707.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494242
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494242 | Dimeric compounds and their use as anti-viral agents | Nov 7, 2002 | Issued |
Array
(
[id] => 479013
[patent_doc_number] => 07223790
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-05-29
[patent_title] => 'Dimeric compounds and their use as anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 10/494260
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7458
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/223/07223790.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494260
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494260 | Dimeric compounds and their use as anti-viral agents | Nov 7, 2002 | Issued |
Array
(
[id] => 7163683
[patent_doc_number] => 20050085533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Novel mandelates salts of substituted tetracyclic tetrahydrofuran derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/491799
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6157
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20050085533.pdf
[firstpage_image] =>[orig_patent_app_number] => 10491799
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/491799 | Mandelates salts of substituted tetracyclic tetrahydrofuran derivatives | Nov 7, 2002 | Issued |
Array
(
[id] => 6660251
[patent_doc_number] => 20030134895
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Method for the preparation of citalopram'
[patent_app_type] => new
[patent_app_number] => 10/291174
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4262
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20030134895.pdf
[firstpage_image] =>[orig_patent_app_number] => 10291174
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/291174 | Method for the preparation of citalopram | Nov 7, 2002 | Issued |
Array
(
[id] => 7207857
[patent_doc_number] => 20050043399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Dimeric compounds and their use as anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 10/494241
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6967
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0043/20050043399.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494241 | Dimeric compounds and their use as anti-viral agents | Nov 7, 2002 | Issued |
Array
(
[id] => 559616
[patent_doc_number] => 07157494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-02
[patent_title] => 'Dimeric compounds and their use as anti-viral agents'
[patent_app_type] => utility
[patent_app_number] => 10/494243
[patent_app_country] => US
[patent_app_date] => 2002-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9791
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/157/07157494.pdf
[firstpage_image] =>[orig_patent_app_number] => 10494243
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/494243 | Dimeric compounds and their use as anti-viral agents | Nov 7, 2002 | Issued |
Array
(
[id] => 7353549
[patent_doc_number] => 20040249167
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Substituted benzopyrans as selective estrogen receptor-beta agonists'
[patent_app_type] => new
[patent_app_number] => 10/493092
[patent_app_country] => US
[patent_app_date] => 2004-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28355
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20040249167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10493092
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/493092 | Substituted benzopyrans as selective estrogen receptor-beta agonists | Nov 6, 2002 | Issued |
Array
(
[id] => 1308606
[patent_doc_number] => 06617463
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-09-09
[patent_title] => 'Method for the production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or s2-keto-L-gulonate esters'
[patent_app_type] => B2
[patent_app_number] => 10/275565
[patent_app_country] => US
[patent_app_date] => 2002-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7186
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/617/06617463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275565
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275565 | Method for the production of L-ascorbic acid by lactonization of 2-keto-L-gulonic acid or s2-keto-L-gulonate esters | Nov 6, 2002 | Issued |
Array
(
[id] => 1173811
[patent_doc_number] => 06750248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-06-15
[patent_title] => 'Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof'
[patent_app_type] => B2
[patent_app_number] => 10/289079
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13793
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/750/06750248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10289079
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/289079 | Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof | Nov 4, 2002 | Issued |
Array
(
[id] => 6856786
[patent_doc_number] => 20030130287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/169399
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10368
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130287.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169399
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169399 | Piperidine and piperazine derivatives which function as 5-ht2a receptor antagonists | Nov 4, 2002 | Abandoned |
Array
(
[id] => 1248765
[patent_doc_number] => 06673929
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-01-06
[patent_title] => 'Process for preparing growth hormone secretagogues'
[patent_app_type] => B2
[patent_app_number] => 10/283720
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13274
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/673/06673929.pdf
[firstpage_image] =>[orig_patent_app_number] => 10283720
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/283720 | Process for preparing growth hormone secretagogues | Oct 29, 2002 | Issued |
Array
(
[id] => 6835436
[patent_doc_number] => 20030162982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-28
[patent_title] => 'Method for the enantioselective preparation of 3,3-diphenyl-2,3-epoxy propionic acid esters'
[patent_app_type] => new
[patent_app_number] => 10/181457
[patent_app_country] => US
[patent_app_date] => 2002-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1967
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0162/20030162982.pdf
[firstpage_image] =>[orig_patent_app_number] => 10181457
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/181457 | Method for the enantioselective preparation of 3,3-diphenyl-2,3-epoxy propionic acid esters | Oct 28, 2002 | Issued |